Cantor Fitzgerald’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Cantor Fitzgerald’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-76,931	Closed	-$3.07K	–	571
2025 Q2	$3.07K	Hold	76,931	–	–	﹤0.01%	441
2025 Q1	$3.17K	Hold	76,931	–	–	﹤0.01%	301
2024 Q4	$6.15K	Hold	76,931	–	–	﹤0.01%	257
2024 Q3	$5.08K	Hold	76,931	–	–	﹤0.01%	200
2024 Q2	$6.77K	Hold	76,931	–	–	﹤0.01%	229
2024 Q1	$6K	Hold	76,931	–	–	﹤0.01%	240
2023 Q4	$2.92K	Hold	76,931	–	–	﹤0.01%	225
2023 Q3	$3.17K	Hold	76,931	–	–	﹤0.01%	535
2023 Q2	$3.62K	Hold	76,931	–	–	﹤0.01%	550
2023 Q1	$12K	Buy	+76,931	New	+$11.7K	﹤0.01%	622

Other funds holding LSBPW

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cantor Fitzgerald's LSBPW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 76,931 shares — an estimated $3.07K sold.

Cantor Fitzgerald first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $12K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

Cantor Fitzgerald reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
Cantor Fitzgerald sold 76,931 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $3.07K.
Cantor Fitzgerald first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
Cantor Fitzgerald's LakeShore Biopharma Warrants position peaked at $12K in Q1 2023.
3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.